Catecholamines and platelet aggregation were studied in relation to physical fitness and psychologic traits of 48 young men at rest and after exercise challenge. Test scores were significantly associated with variables derived from the in vitro reactivity of blood platelets. Men characterized by high time urgency, impatience, haste and irritability had higher platelet counts in their whole blood. They also had less of a decrease in percent of platelet aggregation in response to noradrenalin after exercise, a shorter duration of platelet aggregation time in response to ADP and a greater likelihood of irreversible "second slope" aggregation than the less hurried, more calm men. Men scoring high on the Type A or coronary-prone behavior scale also failed to show a decrease in percent of platelet aggregation in response to noradrenalin after the challenge of exercise, and, in addition, the duration of the aggregation to ADP was much shorter in Type As at rest and relatively unaffected by exercise. In general, Type A men were distinguishable from Type Bs, not so much by their resting values, but by their differential physiologic mobilization to the challenge of exercise. The primary focus of this study was to consider changes in plasma catecholamines and the reactive properties of blood platelets in terms of the psychologic and behavioral characteristics of the people from whom the plasma and platelets were drawn. The possible clinical implications remain to be determined.
INTRODUCTION
An overt behavioral syndrome characterized by extremes of striving for achievement, competitiveness, commitment to job or profession, time urgency and a heightened activity level has been found to be associated with the presence of manifest coronary heart disease (CHD) in a number of studies (1) . The biological mechanisms through which this behavior pattern increases CHD risk are not known, however. Bivariate and multivariate analyses of the data from a prospective epidemiological study indicate that the risk associated with the presence of the behavior pattern is independent of such standard risk fac-tors as blood pressure, serum lipids, obesity and cigarette smoking (2) . A search for possible biological mechanisms that may link the behavior pattern to coronary thrombosis led to a study of plasma catecholamines and blood platelet aggregation. The phenomenon of platelet aggregation and the release of platelet contents are generally considered to be important factors in the genesis of thrombosis and, as suggested by Duguid (3) and others, even in atherogenesis itself through the encrustation hypothesis.
A pilot study done in the summer of 1970 (4) served to acquaint the investigators with some of the problems in studies of these biological parameters and set the stage for more refined methodology and laboratory technique for the present study conducted in the summer of 1971. This is particularly important because some of the laboratory methods used are not yet standard in this country.
METHODS

The Study Group
Forty-eight male college students from 19 to 35 years of age volunteered for this study. They were enrolled in the Summer School at Georgia Southern College, mostly in education and physical education programs. Many had entered fulltime employment and had returned for graduate courses.
Treadmill Test Procedure
Each subject was given at least one preliminary treadmill test before the day of the study in order to become familiar with the testing procedure. All tests in the study were conducted between 7:30 and 10:30 AM. Following 30 minutes of quiet rest in a horizontal position, a resting 60 ml blood sample was expertly drawn using an 18 gauge needle. When any blood sample was unusually difficult to obtain (one instance), the subject was disqualified from the entire study. The Modified Standard Balke test (5) was then performed on a Quinton, Model 24-72 treadmill at a speed of 3.0 mph beginning at a grade of 2.5% (4 mets). Prior to the test the subject walked at this grade for 3 minutes and then rested for 2 minutes. During the test, the grade was increased 2,5% every 2 minutes. Blood pressure and heart rate (beats/15sec) were obtained each minute by auscultation. When the pulse rate reached 180 beats/min or both the pulse rate and the pulse pressure failed to increase following an increase in grade, the test was terminated. The second blood sample was obtained as quickly as possible after exercise; a third blood sample was obtained 15 mintues later. Performance on the treadmill is expressed in mets, one met being equal to the oxygen consumption at rest in a sitting position in 1 minute.
Platelet Aggregation Tests
Platelet aggregation tests were performed immediately after drawing the blood in the room adjacent to the treadmill according to the optical density method of Born (6) and O'Brien (7) . Figure 1 shows the principle involved in this method. Citrated whole blood is centrifuged to obtain platelet-rich plasma. The platelet-rich plasma is stirred at 37°C with a magnetic stirrer while percent transmission of light through the suspension of 
MICHAEL T. SIMPSON, etal.
platelets is determined on an EEL photometer and recorded on a Honeywell 0-10 mv. recorder. Thus, a second-by-second record of the degree of dispersion of the platelets is obtained. Aggregation or "clumping" of platelets will result in increasing transmission of light through the initially turbid solution. Figure 2 represents a normal response to adrenalin or noradrenalin with increased clumping, increased transmission of light and, therefore, a downward curve. Two measurements of platelet aggregation are the reaction time and the intensity or "slope." The reaction time is the interval in seconds from the addition of the aggregating agent, such as ADP or adrenalin, until the first phase of aggregation is completed. The intensity or "slope" of the aggregation is the change in percent transmission of light per minute during the period of most rapid change. It is a measure of the maximum rate of aggregation. The aggregation reaction in response to ADP, in the concentration used here, is reversible and is thought to be caused by the added ADP alone. The reactions to adrenalin and noradrenalin in the concentrations used here initially show aggregation and then stabilize at a given level of light transmission but after a few seconds are often followed by a second and irreversible clumping of platelets, which results in virtually complete clearing of suspended particles from the plasma. This is shown in Fig. 2 as the second slope. The first slope to adrenalin or noradrenalin is thought to be due to the effect of the exogenous adrenalin or noradrenalin, while the second slope is due to endogenously stored ADP released from the platelets and is referred to as the "ADP release reaction" (8, 9) .
When a sample of plasma failed to exhibit the second slope to the injected adrenalin or noradrenalin (0.1 cc of 1 X 10-5 M and 0.1 cc of 1 X 10-4 M, respectively), a second stronger concentration of the catecholamine was then added to test for the second slope to rule out dose-related resistance to the initial weaker aliquot.
Several situations are known to interfere with the ADP release reaction including familial disorders of platelet function (10) , ingestion of certain drugs (11) (12) (13) (14) , and certain states (14) . Drugs that can interfere with the ADP release-secondary aggregation phenomenon are aspirin, dipyridamole, glyceryl quaiacolate, chlorpromazine, phenylbutazone, indomethacin and others. The following precautions were taken to keep these artifacts from distorting the platelet aggregation data: All subjects were strongly warned, both verbally and in writing, against taking aspirin or any other medications during the week prior to their participation in the study. In case of headache or other discomfort, study subjects were to come to one of the principal investigators for alternate medication (acetaminophen), which would not effect the platelets (one instance). Additional ques- 
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tioning prior to the treadmill session provided further support for the belief that all participants had avoided medications as per instructions. Measurements of platelet aggregation are influenced by the number of platelets in the plasma. To permit direct comparison of platelet aggregation between individuals in this study with different plasma platelet counts, the results from each sample of plasma in the study were adjusted by the method of O'Brien (15) to the degree of aggregation that sample would have produced had its platelet count been exactly 400,000/mm 3 .
Plasma Catecholamines
The aliquots of plasma used for catecholamine determinations were promptly frozen and shipped to Case Western Reserve University where they were analyzed by Dr. Aaron H. Anton, using his modified aluminum oxide-trihydroxyindole method (16) .
Psychological Testing
During the week prior to the treadmill exercise and drawing of blood samples, the subjects completed a number of psychological tests. Because of our interest in the possible relationship of the coronary-prone behavior pattern to catecholamines and platelet aggregation, two factors possibly involved in coronary thrombosis, we included a questionnaire designed to measure the coFonary-prone behavior pattern-the Jenkins Activity Survey (or JAS) (17, 18) . The JAS is scored on four scales: the Type A scale, derived by discriminant function methods to predict the clinical rating of Type A and Type B (as conceptualized by Friedman and Rosenman) (1); Factor S, derived by factor analysis, which represents speed, impatience and time urgency; Factor J, which measures job involvement and dedication to career; and Factor H, which taps a harddriving/conscientious dimension. In addition, the Flexibility Scale of the California Psychological Inventory (19) and Spielberger's State-Trait Anxiety Scale (20) were administered.
Statistical Analysis
The study group was divided at the median of the distribution of each score on the Activity Survey, thus yielding a high scoring (more Type A) and a low scoring (more Type B) group. The medians for the Type A and Factor S and Factor H scales were fairly close to those found in the 2619 men on whom this 1969 edition of the JAS was standardized in the Western Collaborative Group Study (WCGS). The median for Factor J (job-involvement) was lower than found in WCGS, which is to be expected in view of the student status of many of the participants.
The mean values of biological variables for the higher and lower scoring groups were tested for differences by one-way analysis of variance (Tables  1-3) . Tables 4-6 are based on two-way analyses of variance. Table 7 represents a division of the study group by the consistency with which their platelets had "second slope" (irreversible aggregation) under the specified conditions. Persons falling between the two clearly delineated groups were excluded. Differences in mean test scores were evaluated by one-way analysis of variance.
When sample sizes are relatively small, when the precision of measurement techniques is not firmly established or when an exploratory study is undertaken, adherence to standard levels of statistical significance, such as the P = .05 level, leads to excess risk of prematurely dismissing relationships between variables that may be genuine but weak (Type II error in statistical terms). To reduce this risk we have chosen to accept the P = 0.10 level of significance as the threshold for reporting a trend or possible association. Findings at the P = 0.05 level will be reported as definite associations. This study is to be considered hypothesis-generating rather than hypothesis-testing by reason of its exploratory nature as well as its less strict statistical level for reporting possible trends.
RESULTS
The associations of various scales of the Activity Survey with catecholamine levels of blood samples taken while resting and after exercise are shown in Table 1 . While different men remained on the treadmill different lengths of time, their degree of challenge was equivalent in the sense that all remained on the treadmill until their pulse reached 180. Table 1 shows that men with a high jobinvolvement score showed a significantly greater increase in adrenalin as a function of the treadmill challenge, even though plasma adrenalin, measured in micrograms per liter, was not different between men scoring high or low on the jobinvolvement scale either at rest or exercise. The other three scales of the JAS did not show a significant association with the change in adrenalin levels. For the scale measuring Type A and Type B behavior dimension, high scorers were not different from low scorers in their level of plasma noradrenalin at rest. It should be noted, however, that after exercise the Type As had marginally significant higher levels of noradrenalin, presumably due to a greater responsiveness to the exercise challenge.
The final portion of Table 1 shows that platelet counts in whole blood differ significantly between men who score high on speed and impatience, as contrasted with those who score low on this scale. This difference in platelet count holds true both for bloods drawn at rest and after exercise. The adjustment procedure of O'Brien for the aggregation variables was a means of controlling these differences in subsequent analyses. Table 2 shows the differences in in vitro platelet responsiveness between men scoring high and low on the coronary-prone behavior pattern. The first part of the table shows that men scoring high on the Type A scale and the job-involvement scale do not differ in the duration of the reaction of their platelets to adrenalin. High scorers, however, tend to show a different direction of change of platelet responsiveness after exercise, as compared to men scoring low on these scales. In men with high Type A and job-involvement scores, the interposition of exercise lengthens the duration of their platelet aggregation reaction by an average of about 5 seconds. Less job-involved, more Type B individuals, in contrast, show a slight decrease in duration of platelet activity after exercise. Differences of this magnitude could occur by chance 10% of the time and hence must be considered as only suggestive.
The percent of change in light transmittance through the stirred platelet solution does not differ by behavior-type groups when adrenalin is used as the aggregating agent. Similarly, aggregation time tonoradrenalin challenge shows no significant differences either at rest or after exercise.
The final part of ever, that the percent change from before to after exercise stress in light transmittance of platelet suspensions when challenged by noradrenalin has an association with the coronary-prone behavior pattern. No differences are observed between groups at rest, but the change after treadmill challenge has a small but significant discrepancy between high and low scoring groups. Exercise is associated with a reduction of the intensity of the aggregation response by about 7>k % among men who score low on Type A and Factor S.
Men scoring high on the scales show a reduction of only about *h% in intensity of the aggregation response. These are, in fact, small absolute differences, but because exercise challenge had only a minimal effect on changing platelet reactivity to noradrenalin in all subjects, a mean difference of this magnitude is statistically unlikely to have occurred by chance. Table 3 shows duration of the platelet aggregation reaction in response to ADP and the nature of its association with the coronary-prone behavior pattern. The responsiveness to ADP of platelets drawn from resting Type A subjects is significantly shorter than that for resting Type B subjects. That is to say, Type A subjects, those high on speed and time urgency, and those who are more hard-driving, competitive and conscientious have platelets whose reaction to ADP is of lesser duration than is the case for platelets from subjects not having these behavioral traits. The challenge of treadmill exercise in Type A subjects causes only a negligible reduction in aggregation time, whereas exercise challenge in the Type B, slowermoving, easy-going subjects shows a substantial shortening of duration. That is statistically significant for the Type A scale and of marginal significance for the harddriving scale.
Earlier work with catecholamines and platelet activity has suggested that physical fitness might be an important influence on these biological parameters (4). Physical fitness was measured in terms of the length of time an individual remained on the treadmill moving at the rate of 3 mph as it was regularly increased in its degree of incline. In this submaximal test all subjects' exercise was terminated when their heart rates reached 180 beats per minute. For men with an average age of 25 years this is estimated to represent approximately 92 % of maximum heart rate and maximum oxygen consumption on the average. In an effort to make an approximately equal physical demand on each man in terms of his own capacity, his own heart rate was used to establish the termination of his exercise. Using these data the oxygen consumption can be estimated for maximal work load for the two groups. The predicted oxygen consumption for the more fit group was 40.3 MI Ch/kg/ min and for the unfit group was 33.2 MI Ch/kg/min.
Treadmill performance was converted into the units called mets. This sample of young men showed a reasonable distribution of physical fitness in terms of mets values. There were very few, however, who could be considered extremely fit. Number of minutes on treadmill was correlated with all the psychological measures using the Spearman rank order coefficient. Only Factor S (speed and impatience) had a significant association (rho = +0.40). The group was divided into the more and less physically fit, with men achieving 10 or more mets of energy expenditure (12V2 or more minutes on treadmill before reaching the termination criterion) being classified as more fit.
All the biological data were analyzed in terms of the fitness measure, and very few variables were found associated. One of these was change in plasma noradrenalin after exercise. This variable was studied for its association with physical fitness and behavior type simultaneously by means of a two-way analysis of variance. These data are shown in Table 4 . The physically fit Type A men showed the biggest increase in plasma noradrenalin after exercise challenge and the less fit among the Type Bs the lowest increase. The anovar summary showed this hormonal change was significantly associated with the physical fitness dimension and only questionably associated with behavior type. Table 5 shows the relation of the duration of the platelet reaction to ADP as a function of these same independent variables. Here we see a marginally significant interaction term. Looking at the table one will note that this is due to the greatly shortened reaction time associated with exercise in Type B physically less fit men. In addition, there is a distinction between the Type As and the Type Bs in change of reaction time, with the Type Bs show- ing a greater curtailment of the reaction The influence of physical fitness, although after exercise. The strength of the interac-not statistically significant itself, clarifies tion makes interpretation of the main ef-statistically the association of behavior fects tenuous, but the table does show the type with intensity of platelet aggregation, importance of both behavior type and The table indicates that on the average, physical fitness in studying platelets in Type A men do not show a reduction in the in vitro system. intensity of aggregation as a function of Table 6 shows the exercise-induced exercise, whereas Type B men do show change in percent aggregation of platelets this "protective effect." to the in vitro challenge of noradrenalin.
Finally, we turn to the issue of irreversible platelet aggregation. This was induced in the present studies by adding adrenalin or noradrenalin to the stirred platelet-rich plasma. The amount of catecholamine introduced by pipette was many times the concentration ordinarily encountered physiologically. Nevertheless, one-third to one-half of the subjects did not show this "second slope" or permanent aggregation reaction. All three blood samples from each individual were challenged with two concentrations of adrenalin and noradrenalin, respectively. The persons who consistently showed "second slopes" to the more dilute concentration of amine are labeled easy aggregators in Table 7 . Those who did not show second slope, even with a stronger concentration of adrenalin, are listed as resisting aggregation. Persons with inconsistent reactions among their three blood samples were omitted from the analysis. Only a few persons resisted aggregation completely to the concentrations of noradrenalin used. Therefore, for that portion of the table, all persons not showing easy aggregation were grouped together and contrasted against the easy aggregators.
It will be noted from Table 7 that persons who consistently showed the irreversible aggregation response (easy aggregators) to the adrenalin challenge scored considerably higher on the Type A scale, showed more speed and impatience and were more inflexible on the CPIFlexibility Scale than those persons whose platelets resisted aggregation to this chemical challenge.
Similar findings hold for response to the noradrenalin challenge. Here the Pvalues are of marginal significance for the most part, but the trends are interesting and the mean differences are of meaningful absolute size. Here again, easy aggregators tend more to be Type A persons who show greater speed and impatience and more rigidity. In addition, easy aggregation to noradrenalin challenge was associated with lower levels of anxiety (measured by Spielberger's Trait Anxiety Scale). This association was not present under circumstances of adrenalin challenge.
The present data suggest that persons who have behavior Type B and who are easy-going with regard to time and flexible in their personal reactions are notably less likely to have blood platelets easily stimulated to the kind of release reactions that result in irreversible clumping of platelets. It must be emphasized that these observations are derived from an artificial in vitro system. If, however, the same principle holds in living subjects, it may have substantial implications.
DISCUSSION
Catecholamines and platelet aggregation were studied in relation to physical fitness and psychological traits of young men at rest and after exercise challenge. Test scores on scales pertinent to the coronary-prone behavior pattern were significantly associated with several of the variables derived from the in vitro reactivity of blood platelets.
Men characterized by high time urgency, impatience, haste and irritability had higher platelet counts in their whole blood. They showed less of a decrease in intensity of aggregation to noradrenalin as a function of exercise than did less hurried, more calm men. Men who scored high on speed and impatience showed a shorter duration of the aggregation reaction to ADP. In addition, these men more frequently exhibited the secondary reaction of irreversible aggregation, presumably as a function of more easy triggering of the ADP release reaction from the platelets themselves.
Men scoring high on the Type A, or coronary-prone trait scale, were similar to those characterized by impatience and speed, in that they failed to show a decrease in percent of platelet aggregation in response to noradrenalin after the challenge of exercise. The duration of the aggregation to ADP was much shorter in Type As at rest and was relatively unaffected by exercise. In contrast, Type Bs had a longer duration of reaction at rest, but this was shortened as a function of exercise.
Men scoring high on job-involvement showed a significantly higher increase in plasma adrenalin after exercise than did low scorers. Men scoring high on the hard-driving scale shared with those scoring high on Type A and S scales the tendency to a shorter aggregation time of platelets to ADP. Exercise challenge triggered a much larger increase in plasma noradrenalin in the physically fit than in the unfit. This may have been due, at least in part, to the different lengths of time they were actively exercising and the different absolute rates of oxygen consumption before reaching the heart rate criterion for termination of this submaximal test. These individual differences in length of time on the treadmill and rate of oxygen consumption do not complicate the interpretation of differences found between high and low scorers on the Type A scale of the JAS because these scores are not significantly correlated with either of these two exercise variables.
Men whose platelets show a secondary permanent aggregation response (second slope) to adrenalin or noradrenalin introduced in vitro differed from men whose platelets did not respond thus in that the "permanent aggregators" scored higher on the coronary-prone behavior pattern and were more hurried, impatient and rigid.
It would be tempting to attempt to make clinical predictions from these in vitro findings, but such speculations are premature. Much of the reduction in reaction time experienced by Type B subjects after exercise may be a function of the longer duration shown by their resting samples rather than a specific protective effect of exercise for Type B subjects. In these in vitro determinations there was a small negative correlation between intensity of the aggregation response (percent change of light transmission) and aggregation time. Thus, for more than half of the subjects a longer aggregation time was associated with a less intense rate of aggregation per minute of the reaction. Similarly, the marginal trend for Type A men to elaborate more plasma noradrenalin during exercise means that their platelets have been immersed in a pool of plasma qualitatively somewhat different than was the case for platelets in Type B men. This prior in vivo difference may change the potential for platelets to react to subsequent in vitro challenges.
Study of the reactive properties of blood platelets is still in its infancy, relatively speaking. Study of the psychological and behavioral characteristics of the people to whom these platelets have belonged is even less developed. We hesitate to speculate on possible clinical implications of these findings. The relation of O' Brien's in vitro system to in vivo dynamics has not been clearly established. In addition, too many unknowns still exist with regard to the role of platelet involvement in cardiovascular diseases. The present study has shown, however, that appropriately selected, adequately standardized, self-administered psychological scales are feasible adjuncts to hematologic studies and might, in fact, provide useful clues to the linkages between behavior and cardiovascular disease that have been observed epidemiologically.
